BridgeBio Pharma Inc (BBIO)
31.14
-2.93
(-8.60%)
USD |
NASDAQ |
Apr 04, 15:15
BridgeBio Pharma Profit Margin (Quarterly): -4.51K% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -14.12% |
| Pfizer Inc | 2.31% |
| Catalyst Pharmaceuticals Inc | 39.44% |
| Plus Therapeutics Inc | -- |
| Insmed Inc | -225.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -70.97% |
| Return on Invested Capital | -108.7% |
| Gross Profit Margin (Quarterly) | 64.57% |
| Operating Margin (Quarterly) | -3.76K% |
| Return on Net Operating Assets | -591.3% |